SOAP Note Documentation for Post-Viral Cough with Mild Wheeze
For a patient presenting with post-viral cough and mild wheeze, document the clinical presentation systematically, assess for red flags requiring further workup, and outline a stepwise treatment approach prioritizing inhaled ipratropium as first-line therapy.
Subjective Section
Document the following specific elements:
- Duration of cough: Specify if <3 weeks (acute), 3-8 weeks (subacute/post-infectious), or >8 weeks (chronic, requiring reclassification) 1, 2
- Preceding viral illness: Note recent upper respiratory infection symptoms (nasal congestion, sore throat, fever) 3, 1
- Cough characteristics: Frequency, productivity, presence of paroxysms, post-tussive vomiting, or inspiratory whooping (suggests pertussis) 1, 2
- Associated symptoms: Wheeze, breathlessness, chest tightness, fever, fatigue 4, 3
- Red flag symptoms: Hemoptysis, significant weight loss, voice changes, prolonged fever, night sweats 4, 3, 1
- Medication history: Specifically document ACE inhibitor use (common cause of persistent cough) 1
- Smoking history: Current or past use with quantification 1
- Impact on quality of life: Sleep disruption, work/school absence, severity of distress 2
Objective Section
Include these specific findings:
- Vital signs: Temperature, respiratory rate (tachypnea >30/min suggests pneumonia), heart rate, oxygen saturation 4
- Lung examination: Document presence/absence of wheeze, crackles, diminished breath sounds, or normal findings 4
- General appearance: Signs of respiratory distress, use of accessory muscles 4
- Additional findings: Presence of nasal discharge, pharyngeal erythema if relevant 3
Do not routinely order chest radiography unless vital signs are abnormal or clinical examination suggests pneumonia 4. Do not routinely measure procalcitonin 4. Consider C-reactive protein only if pneumonia is suspected (CRP >30 mg/L increases likelihood; <10 mg/L makes it unlikely) 4.
Assessment Section
Structure your assessment as follows:
- Primary diagnosis: Post-viral cough with mild wheeze (if cough duration 3-8 weeks following viral illness) 1, 2
- Differential considerations documented:
- Severity assessment: Mild (normal vital signs, minimal impact) vs. severe (quality of life significantly affected) 2
- Red flags: Present or absent 3, 1
Plan Section
First-Line Treatment (Document Specific Orders)
- Inhaled ipratropium bromide: Prescribe as first-line therapy (has demonstrated efficacy in controlled trials for post-infectious cough) 3, 2
- Honey: Recommend for patients >1 year old (avoid in infants <1 year due to botulism risk) 3
- Hydration: Advise adequate fluid intake (no more than 2 liters daily) 3
- Positioning: Avoid lying flat on back 3
- Symptomatic relief: Dextromethorphan-containing remedies, menthol lozenges 3
Second-Line Treatment (If First-Line Fails)
- Inhaled corticosteroids: Consider when cough adversely affects quality of life or persists despite ipratropium 3, 2
- Oral prednisone 30-40 mg daily: For severe paroxysms, short finite period only, after ruling out upper airway cough syndrome, asthma, or GERD 3, 2
For Wheeze Component
- Bronchodilator therapy: Short-acting beta-agonist (salbutamol/albuterol) as needed for wheeze 5
- Reassess for asthma: If wheeze persists or recurs, consider trial of inhaled corticosteroids for possible cough-variant asthma 4, 1
What NOT to Do (Document Explicitly)
- No antibiotics: Unless confirmed bacterial infection (post-viral cough is not bacterial) 3, 2
- No routine antipyretics: Do not use solely to reduce temperature 3
Follow-Up Plan
- Routine follow-up in 4-6 weeks 1, 2
- Reclassify as chronic cough if persists >8 weeks: Requires full chronic cough workup at that point 1, 2
- Return precautions: Hemoptysis, worsening breathlessness, high fever, symptoms beyond 3 weeks 3
Patient Education (Document Counseling)
- Expected duration: Post-viral cough typically resolves within 3-8 weeks 1, 2
- Natural history: 10% of viral coughs last >20-25 days 4
- When to seek urgent care: Red flag symptoms 3
Common Documentation Pitfalls to Avoid
- Failing to specify cough duration precisely: This determines classification (acute vs. subacute vs. chronic) and management approach 1, 2
- Not documenting ACE inhibitor review: A frequently missed reversible cause 1
- Prescribing antibiotics without bacterial confirmation: Contributes to antimicrobial resistance 3, 2
- Missing pertussis consideration: Often underdiagnosed in adults with prolonged cough 1, 2